115 related articles for article (PubMed ID: 9805259)
1. Effect of beta-blocker treatment in dilated cardiomyopathy with bradyarrhythmias.
Suwa M; Ito T; Otake Y; Kobashi A; Hirota Y; Kawamura K
Jpn Circ J; 1998 Oct; 62(10):765-9. PubMed ID: 9805259
[TBL] [Abstract][Full Text] [Related]
2. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy.
Suwa M; Otake Y; Moriguchi A; Ito T; Hirota Y; Kawamura K; Adachi I; Narabayashi I
Am Heart J; 1997 Mar; 133(3):353-8. PubMed ID: 9060806
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of patients with dilated cardiomyopathy and bradyarrhythmias.
Ando S; Koyanagi S; Muramatsu K; Itaya R; Takeshita A; Nakamura M
J Cardiol; 1991; 21(1):53-9. PubMed ID: 1817181
[TBL] [Abstract][Full Text] [Related]
4. Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: prediction of response to beta-blocker therapy.
Suwa M; Ito T; Kobashi A; Yagi H; Terasaki F; Hirota Y; Kawamura K
Am Heart J; 2000 May; 139(5):905-12. PubMed ID: 10783226
[TBL] [Abstract][Full Text] [Related]
5. Sudden cardiac death in dilated cardiomyopathy -- therapeutic options.
Grimm W; Maisch B
Herz; 2002 Dec; 27(8):750-9. PubMed ID: 12574892
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the therapeutic effects of the beta-blocking agent bisoprolol and the calcium-blocking agent diltiazem in patients with heart failure due to dilated cardiomyopathy.
Suwa M; Ito T; Otake Y; Moriguchi A; Hirota Y; Kawamura K
Jpn Circ J; 1996 Oct; 60(10):767-73. PubMed ID: 8933239
[TBL] [Abstract][Full Text] [Related]
7. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.
Yamazaki J; Muto H; Kabano T; Yamashina S; Nanjo S; Inoue A
Am Heart J; 2001 Apr; 141(4):645-52. PubMed ID: 11275933
[TBL] [Abstract][Full Text] [Related]
9. Effect of beta-blocker therapy on myocardial perfusion defects in thallium-201 scintigraphy in patients with dilated cardiomyopathy.
Hara Y; Inoue K; Ogimoto A; Ohtsuka T; Shigematsu Y; Nakata S; Higaki J
Cardiology; 2005; 104(1):16-21. PubMed ID: 15942178
[TBL] [Abstract][Full Text] [Related]
10. [The relationship between the improvement of cardiac function and the myocardial uptake of I-123 metaiodobenzylguanidine in patients with dilated cardiomyopathy treated by beta-blocker].
Wakita T; Numata Y; Ogata Y; Harada E; Mizumasa Y
J Cardiol; 1995 Sep; 26(3):177-83. PubMed ID: 7473048
[TBL] [Abstract][Full Text] [Related]
11. Beta-blocker titration failure is independent of severity of heart failure.
Anthonio RL; van Veldhuisen DJ; Breekland A; Crijns HJ; van Gilst WH
Am J Cardiol; 2000 Feb; 85(4):509-12, A11. PubMed ID: 10728963
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of exercise-induced T wave changes in patients with idiopathic dilated cardiomyopathy before and after beta-blocker therapy.
Hara H; Niwano S; Hirasawa S; Sasaki T; Ikeda N; Izumi T
J Cardiovasc Electrophysiol; 2006 Aug; 17(8):865-70. PubMed ID: 16903965
[TBL] [Abstract][Full Text] [Related]
13. Effect of beta-blocker therapy in elderly patients with dilated cardiomyopathy.
Hara Y; Hamada M; Shigematsu Y; Ohtsuka T; Ogimoto A; Suzuki J; Higaki J
Circ J; 2003 Oct; 67(10):826-9. PubMed ID: 14578613
[TBL] [Abstract][Full Text] [Related]
14. Exercise-induced upward shift of diastolic left ventricular pressure-volume relation in patients with dilated cardiomyopathy. Effects of beta-adrenoceptor blockade.
Sato H; Hori M; Ozaki H; Yokoyama H; Imai K; Morikawa M; Takeda H; Inoue M; Kamada T
Circulation; 1993 Nov; 88(5 Pt 1):2215-23. PubMed ID: 8106181
[TBL] [Abstract][Full Text] [Related]
15. Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy.
Ohtsuka T; Hamada M; Hiasa G; Sasaki O; Suzuki M; Hara Y; Shigematsu Y; Hiwada K
J Am Coll Cardiol; 2001 Feb; 37(2):412-7. PubMed ID: 11216955
[TBL] [Abstract][Full Text] [Related]
16. Post-myocardial infarction beta-blocker therapy: the bradycardia conundrum. Rationale and design for the Pacemaker & beta-blocker therapy post-MI (PACE-MI) trial.
Goldberger JJ; Bonow RO; Cuffe M; Dyer A; Greenland P; Rosenberg Y; O'Rourke R; Shah PK; Smith S
Am Heart J; 2008 Mar; 155(3):455-64. PubMed ID: 18294477
[TBL] [Abstract][Full Text] [Related]
17. Can beta-blocker therapy be withdrawn from patients with dilated cardiomyopathy?
Morimoto S; Shimizu K; Yamada K; Hiramitsu S; Hishida H
Am Heart J; 1999 Sep; 138(3 Pt 1):456-9. PubMed ID: 10467195
[TBL] [Abstract][Full Text] [Related]
18. A sustained increase in beta-adrenoceptors during long-term therapy with metoprolol and bisoprolol in patients with heart failure from idiopathic dilated cardiomyopathy.
Yamada S; Ohkura T; Uchida S; Inabe K; Iwatani Y; Kimura R; Hoshino T; Kaburagi T
Life Sci; 1996; 58(20):1737-44. PubMed ID: 8637398
[TBL] [Abstract][Full Text] [Related]
19. An appropriate indication for the initiation of beta-blocker therapy in dilated cardiomyopathy.
Morooka T; Inoue T; Kotooka N; Fujimatsu D; Komatsu A; Uchida F; Yoshida K; Hashimoto S; Hikichi Y; Kato T; Node K
Cardiology; 2006; 105(1):61-6. PubMed ID: 16272814
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of 123I-MIBG scintigraphy for prediction of effect of beta-blocker therapy in dilated cardiomyopathy].
Tawarahara K; Sugiyama T; Nakano T; Matou F; Kurata C; Wakabayashi Y; Shouda S; Mikami T
Kaku Igaku; 1998 Jul; 35(6):413-20. PubMed ID: 9753920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
